What is the appropriate treatment for premenstrual syndrome in a 15-year-old non‑sexually active female?

Treatment of PMS in a 15-Year-Old Non-Sexually Active Female

Start with lifestyle modifications (exercise, stress reduction, healthy diet) and calcium carbonate 1200 mg daily as first-line therapy, reserving SSRIs for severe symptoms or treatment failures 1, 2.

Initial Management Approach

For adolescents with PMS, treatment should follow a stepwise algorithm based on symptom severity:

Step 1: Lifestyle Modifications and Calcium Supplementation

• Calcium carbonate 1200 mg/day has level I evidence for efficacy and should be the initial pharmacologic intervention for mild-to-moderate PMS 2
• Recommend regular aerobic exercise and stress reduction techniques, though evidence is inconclusive, these carry overall health benefits with no risk 2
• Encourage a complex carbohydrate-rich diet 2

Step 2: Confirm Diagnosis with Prospective Tracking

Before escalating therapy, require prospective daily symptom charting for at least two complete menstrual cycles 1, 3, 4. This is critical because:

• Many conditions mimic PMS (depression, anxiety disorders, menstrual migraine) 5
• Symptoms must be luteal-phase specific and resolve with menses to confirm PMS/PMDD 5, 4
• Retrospective recall is unreliable 5

Step 3: Pharmacotherapy for Moderate-to-Severe Symptoms

If calcium and lifestyle modifications fail after 2-3 cycles, selective serotonin reuptake inhibitors (SSRIs) are the evidence-based next step 1, 6, 5:

• SSRIs have the strongest evidence for efficacy in PMS/PMDD 6, 5, 3
• FDA-approved options include fluoxetine, controlled-release paroxetine, and sertraline 6
• Intermittent luteal-phase-only dosing is effective for most patients and may improve tolerability 5
• Continuous dosing is an alternative 3

Important Considerations for Adolescents

The 2023 ACOG guideline explicitly states that recommendations for adults apply to adolescents with few exceptions 1. However, for a non-sexually active 15-year-old:

• Avoid hormonal contraceptives as initial therapy since she doesn't need contraception and these have less robust evidence than SSRIs for PMS 6, 5
• Hormonal suppression of ovulation should be reserved for SSRI failures 5, 3

Treatments to Avoid

Do not prescribe progesterone or bromocriptine—these are ineffective despite historical use 2.

Evidence for vitamin B6 and evening primrose oil is inconclusive 2, though they may be tried given low risk.

Common Pitfalls

• Failing to obtain prospective symptom tracking leads to misdiagnosis—many patients with continuous depression mistakenly attribute symptoms to their cycle 5, 4
• Starting with hormonal contraceptives when SSRIs have superior evidence for PMS treatment 6, 5
• Not recognizing that PMDD carries elevated suicidality risk, requiring more aggressive intervention 4

Algorithm Summary

1. Mild symptoms: Lifestyle modifications + calcium carbonate 1200 mg/day
2. Persistent symptoms: Prospective tracking × 2 cycles to confirm diagnosis
3. Moderate-severe confirmed PMS/PMDD: Add SSRI (luteal-phase or continuous dosing)
4. SSRI failures only: Consider hormonal ovulation suppression

This stepwise approach balances evidence quality with the developmental needs of an adolescent patient 1, 6, 5, 2.